Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Laura A. Lambert

Dr. Laura A. Lambert

Surgical Oncologist

Dr. Laura Lambert is a surgical oncologist and director of the Peritoneal Malignancy Program at the University of Utah’s Huntsman Cancer Institute in Salt Lake City.

Get in touch
Jump to a Topic:

About Laura A. Lambert

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

  • Works for Specialty Center icon

    Works for Specialty Center

  • Board Certified icon

    Board Certified in Surgery

Lambert has extensive experience in treatment for patients with peritoneal mesothelioma, a rare and aggressive cancer that starts in the abdominal lining but often spreads to surrounding organs.

She specializes in performing hyperthermic intraperitoneal chemoperfusion, often called HIPEC, in combination with cytoreductive surgery for several types of abdominal cancer.

The innovative cytoreduction/HIPEC combination is done only in select cancer centers around the country. It has increased the survival rate dramatically for patients with peritoneal mesothelioma.

“For some patients, HIPEC is a source of new hope,” Lambert said. “Standard chemotherapy and surgery alone offer limited success. Certain stage IV cancers can benefit from HIPEC.”

Lambert was recruited to the Huntsman Cancer Institute in 2018 for her expertise, making Huntsman the only cancer center in Utah to offer the HIPEC procedure.

Delivering Chemotherapy Straight to the Tumor Site

HIPEC is a different approach to chemotherapy. Instead of traditional systemic delivery to the bloodstream, in HIPEC a heated chemotherapy solution is pumped directly into the abdominal cavity, circulated for up to 90 minutes, and then removed.

This procedure is designed to kill any microscopic tumor cells that evade the surgeon, lessening the chance for tumor recurrence.

“It will give patients and health care providers an important treatment option they either would not have, or for which they would have to travel great distances,” Lambert said.

The procedure is also used with cancers of the appendix and colon, along with the management of gynecologic malignancies.

Focused and Distinguished Career

Lambert started her career at the MD Anderson Cancer Center in Houston as an assistant professor in surgical oncology.

Then she served at the University of Massachusetts Medical Center, where she helped refine the use of the HIPEC/cytoreduction combination.

While working at the University of Massachusetts, she earned an additional board certification in palliative medicine. She also led the formation of the UMass Appendiceal Cancer Research group.

Lambert earned her degree from the Harvard Medical School. She did her residency in general surgery at the Dartmouth-Hitchcock Medical Center in New Hampshire before a two-year fellowship in surgical oncology at MD Anderson.

Disclaimer: Dr. Laura A. Lambert has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Daniel King, Content Writer for
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.


Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 30, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now